HealthCap — Full Portfolio
35 tracked investments · listed companies and verified rows first
Pulmonx develops the Zephyr Valve, a bronchoscopic medical device for treating severe COPD and emphysema without surgery.
HealthtechMedical DevicesSan Jose, US
GLENDON E. FRENCH(Executive Officer, Director)DANA G. MEAD, JR(Director)STEPHEN SALMON(Director)RODNEY PERKINS, M.D.(Director)OERN STUGE(Director)MICHAEL MATLY(Director)
Board seatStaffan Lindstrand· per SEC Form D
BiotechSouth San Francisco, US
Javier Szwarcberg(Executive Officer, Director)Samir Gharib(Executive Officer)RICHARD KING(Executive Officer, Director)CAMILLA SIMPSON(Director)
BoardSimpson Camilla(Director)Tiba Aynechi(Director)
Board seatJonas Hansson· per SEC Form D
BiotechDoylestown, US
John P. Hamill(Executive Officer)Oren Gilad(Executive Officer, Director)
BoardJean-Pierre Bizzari(Director)Gabriela Gruia(Director)Rifat Pamukcu(Director)Bernd Seizinger(Director)
Hemab is a biotechnology company developing targeted prophylactic therapies for people with serious bleeding and blood coagulation disorders that lack adequate treatment options.
BiotechHealthtech
Incardatherapeutics develops drug therapies for treating atrial fibrillation using synergistic combinations of anti-arrhythmic agents, with delivery platforms designed for both hospital and at-home settings.
BiotechDigital HealthMedical DevicesBrisbane, US
Rangachari Narasimhan(Executive Officer, Director)McCarthy Reenie(Director)Grace Colon(Executive Officer, Director)Bischofberger Norbert(Director)Miller Samantha(Executive Officer)
Board seatJohan Christenson· per SEC Form D
BiotechRaleigh, US
Robert Seltzer(Director)Jaikrishna Patel(Executive Officer)Marco Taglietti(Director)Pierre Legault(Executive Officer, Director)James Mitchum(Director)John Hamill(Executive Officer)
Board seatEugen Steiner· per SEC Form D · $28.5M raise · filed Nov 2015
Adcendo develops antibody-drug conjugates (ADCs) targeting cancers with high unmet medical need.
BiotechMedical Devices
AMRA Medical provides MRI-based body composition analytics that generate fat and muscle biomarkers for clinical trials and clinical decision-making.
AI & Machine LearningHealthtechMedical Devices
RxList is an online drug information reference that provides details on prescription medications, drug classifications, comparisons, vitamins and supplements.
Digital HealthHealthtechMedia & Entertainment
BiotechPhiladelphia, US
Susan B Dillon(Executive Officer, Director)Karyn O'Neil(Executive Officer, Director)Mark V. Laurenzi(Executive Officer)Elizabeth Anderson(Director)
BoardBruce Peacock(Director)
BiotechPhiladelphia, US
Steven Kelly(Executive Officer, Director)Margarita Chavez(Director)Eran Nadav(Director)Althea Stillman(Director)Jacob Gunterberg(Director)Regina Hodits(Director)
CurifyLabs develops an automated compounding system for pharmacies that uses robotics, GMP-manufactured excipient bases, and integrated quality control software to enable faster, safer preparation of customized medications.
Digital HealthHealthtechMedical DevicesHelsinki, FI
Charlotta TopeliusNiklas Sandler Topelius
Fusion Pharma develops targeted alpha therapeutics for cancer treatment using proprietary linker technology to connect alpha-emitting medical isotopes to cancer-targeting molecules, delivering lethal damage to tumor cells while minimizing toxicity to healthy tissues.
BiotechHealthtechMedical Devices
BiotechSouth San Francisco, US
Yael Weiss(Executive Officer, Director)
BoardCamille Samuels(Director)Marten Steen(Director)Shalini Sharp(Director)Stephen Farr(Director)
Neobiomics develops dietary supplement products, including ProPrems and NeoMega36, aimed at supporting the health and development of preterm infants, such as normal vision function.
BiotechFoodTechHealthtech
Oncorena is developing orellanine as a potential treatment for metastatic renal cell carcinoma and is running a clinical trial to evaluate its safety, tolerability, and anti-tumor efficacy in patients with metastatic clear-cell or papillary renal cell carcinoma.
BiotechHealthtech
Aerogen develops vibrating mesh nebuliser technology for aerosol drug delivery used across critical care, emergency care, and ventilated and non-ventilated respiratory therapies.
HealthtechMedical Devices
Pretzel Therapeutics develops therapeutics targeting bioenergetic dysfunction and mitochondrial disease by addressing defects in mitochondrial DNA function and gene expression.
BiotechDeep TechHealthtechMedical Devices
Michal Minczuk(Co-Founder)Gabriel Martinez(Chief Scientific Officer & Co-Founder)Claes Gustafsson(Co-Founder)Maria Falkenberg(Co-Founder)Nils-Göran Larsson(Co-Founder)Jay Parrish(Chief Executive Officer & Chairman of the Board)
SynOx Therapeutics develops treatments for people with tenosynovial giant cell tumours (TGCT) and other macrophage-mediated diseases.
BiotechHealthtech
Vicore Pharma is a clinical-stage biopharmaceutical company developing treatments for diseases in which the AT2 (angiotensin II type 2) receptor plays a central role.
BiotechHealthtech
Vivet Therapeutics is a company focused on gene and cell therapy development, presenting research at major scientific conferences.
BiotechParis, FR
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.